MT-110
MT-110 (BPN-0027490) is a selective and blood-brain barrier permeable non-muscle myosin II inhibitor. MT-110 markedly improves tolerability by selectively targeting NMII over CMII. MT-110 can be used the study of neurological disease[1].
Product Specifications
CAS Number
[2404652-82-8]
Product Name Alternative
BPN-0027490
UNSPSC
12352005
Target
Myosin
Related Pathways
Cytoskeleton
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
O=C1[C@@]2(O)C(N(C3=CC=C4N=C(C)C=CC4=C3)CC2)=NC5=C1C=C(C)C(C)=C5
Molecular Formula
C23H21N3O2
Molecular Weight
371.43
References & Citations
[1]Radnai L, et al. Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic Potential. bioRxiv [Preprint]. 2024 Oct 12:2024.10.07.617018.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
154838-01 10 µg
Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Recombinant, Human
Ask
View Details 
154838-02 50 µg
Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Recombinant, Human
Ask
View Details 154838-03 200 µg
Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) Recombinant, Human
Ask
View Details GTR15401306 1 Vial
Lentiviral human FAM200B sgRNA gene knockout kit - Lentiviral human FAM200B sgRNA gene knockout kit (plasmid)
Ask
View Details 